Deep-pocketed investors have adopted a bearish approach towards DexCom DXCM, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DXCM usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for DexCom. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable options, 5 are puts, totaling $298,900, and 3 are calls, amounting to $135,188.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $100.0 for DexCom over the last 3 months.
Analyzing Volume & Open Interest
In terms of liquidity and interest, the mean open interest for DexCom options trades today is 150.43 with a total volume of 1,255.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for DexCom's big money trades within a strike price range of $60.0 to $100.0 over the last 30 days.
DexCom Option Activity Analysis: Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DXCM | PUT | TRADE | NEUTRAL | 03/20/26 | $6.5 | $6.1 | $6.3 | $60.00 | $189.0K | 3 | 300 |
| DXCM | CALL | SWEEP | BEARISH | 01/16/26 | $12.8 | $12.5 | $12.5 | $70.00 | $78.7K | 291 | 63 |
| DXCM | CALL | SWEEP | BULLISH | 04/17/25 | $0.8 | $0.75 | $0.8 | $76.00 | $30.4K | 99 | 848 |
| DXCM | PUT | TRADE | BEARISH | 06/20/25 | $29.5 | $28.5 | $29.5 | $100.00 | $29.5K | 412 | 10 |
| DXCM | PUT | TRADE | NEUTRAL | 06/20/25 | $29.5 | $28.5 | $29.0 | $100.00 | $29.0K | 412 | 20 |
About DexCom
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Having examined the options trading patterns of DexCom, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
DexCom's Current Market Status
- With a trading volume of 2,643,548, the price of DXCM is down by -0.21%, reaching $71.98.
- Current RSI values indicate that the stock is may be oversold.
- Next earnings report is scheduled for 28 days from now.
What Analysts Are Saying About DexCom
In the last month, 1 experts released ratings on this stock with an average target price of $104.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for DexCom, targeting a price of $104.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest DexCom options trades with real-time alerts from Benzinga Pro.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
